[
  {
    "ts": "2025-10-31T23:00:00+00:00",
    "headline": "SNAP benefits expire, open enrollment, earnings: What to Watch",
    "summary": "Market Domination Overtime host Josh Lipton previews several of the biggest stories to come throughout next week, including: — The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a federal judge orders the Trump administration to continue funding the program. — Earnings results from Berkshire Hathaway (BRK-A, BRK-B) this Saturday and quarterly results from companies like Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Qualcomm (QCOM), and McDonald's (MCD) throughout the rest of the week — The beginning of open enrollment for health insurance coverage. — Economic commentary from a handful of Federal Reserve officials. — Tesla's (TSLA) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "e1f87b30-9252-38da-82fb-62de5107c59a",
      "content": {
        "id": "e1f87b30-9252-38da-82fb-62de5107c59a",
        "contentType": "VIDEO",
        "title": "SNAP benefits expire, open enrollment, earnings: What to Watch",
        "description": "<p>Market Domination Overtime host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/josh-lipton/\">Josh Lipton</a> previews several of the biggest stories to come throughout next week, including:</p>\n<p>— The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a f<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/video/judge-orders-trump-admin-fund-195640649.html\">ederal judge orders the Trump administration</a> to continue funding the program.</p>\n<p>— Earnings results from Berkshire Hathaway (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/BRK-A\">BRK-A</a>, <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/BRK-B\">BRK-B</a>) this Saturday and quarterly results from companies like Palantir Technologies (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/PLTR\">PLTR</a>), Advanced Micro Devices (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Qualcomm (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/QCOM\">QCOM</a>), and McDonald's (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/MCD\">MCD</a>) throughout the rest of the week</p>\n<p>— The beginning of open enrollment for health insurance coverage.</p>\n<p>— Economic commentary from a handful of Federal Reserve officials.</p>\n<p>— Tesla's (<a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/quote/TSLA\">TSLA</a>) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:10;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Market Domination Overtime host Josh Lipton previews several of the biggest stories to come throughout next week, including: — The nearing expiration of SNAP benefits funding (Supplemental Nutrition Assistance Program) as a federal judge orders the Trump administration to continue funding the program. — Earnings results from Berkshire Hathaway (BRK-A, BRK-B) this Saturday and quarterly results from companies like Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Qualcomm (QCOM), and McDonald's (MCD) throughout the rest of the week — The beginning of open enrollment for health insurance coverage. — Economic commentary from a handful of Federal Reserve officials. — Tesla's (TSLA) shareholder meeting, where investors will vote on CEO Elon Musk's $1 trillion executive pay package. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Domination Overtime.",
        "pubDate": "2025-10-31T23:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9qbUL9KtcGpPO21afrFgaw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.X3teJvg1tp5IiAlWO9TfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/e9779a30-b694-11f0-aff0-d4d40d83b8c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/snap-benefits-expire-open-enrollment-230000448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "FANG"
            },
            {
              "symbol": "ON"
            },
            {
              "symbol": "RYAAY"
            },
            {
              "symbol": "RYAOF"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "BRK-B"
            },
            {
              "symbol": "TM"
            },
            {
              "symbol": "TOYOF"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "EBBGF"
            },
            {
              "symbol": "EBBNF"
            },
            {
              "symbol": "EBGEF"
            },
            {
              "symbol": "EBRZF"
            },
            {
              "symbol": "ENB"
            },
            {
              "symbol": "ENBFF"
            },
            {
              "symbol": "ENBHF"
            },
            {
              "symbol": "ENBMF"
            },
            {
              "symbol": "ENBNF"
            },
            {
              "symbol": "ENBRF"
            },
            {
              "symbol": "ENBSF"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "L"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "VST"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "AFRM"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "DUK-PA"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "QCOM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T17:53:00+00:00",
    "headline": "Rigel Gears Up to Report Q3 Earnings: Here's What to Expect",
    "summary": "RIGL's rising Tavalisse sales, along with incremental sales from Rezlidhia and Gavreto, could power another earnings beat in the quarter to be reported.",
    "url": "https://finance.yahoo.com/news/rigel-gears-report-q3-earnings-175300272.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8470ec2b-544b-3ffa-bd45-2a02bceeefc6",
      "content": {
        "id": "8470ec2b-544b-3ffa-bd45-2a02bceeefc6",
        "contentType": "STORY",
        "title": "Rigel Gears Up to Report Q3 Earnings: Here's What to Expect",
        "description": "",
        "summary": "RIGL's rising Tavalisse sales, along with incremental sales from Rezlidhia and Gavreto, could power another earnings beat in the quarter to be reported.",
        "pubDate": "2025-10-31T17:53:00Z",
        "displayTime": "2025-10-31T17:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H9Y3er.afSc3GhCdnEPJDg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A8kFZZ9VHNy5RXuATQIZdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rigel-gears-report-q3-earnings-175300272.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rigel-gears-report-q3-earnings-175300272.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RIGL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T05:30:00+00:00",
    "headline": "Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.",
    "summary": "The growth for Vertex’s Journavax painkiller is just beginning to ramp up, given the potential size of the nonaddictive drug market.",
    "url": "https://www.barrons.com/articles/vertex-pharmaceutials-stock-tumbled-earnings-pain-4c8409f8?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ecf234d0-4e0e-3f80-a374-50144cc8f21f",
      "content": {
        "id": "ecf234d0-4e0e-3f80-a374-50144cc8f21f",
        "contentType": "STORY",
        "title": "Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.",
        "description": "",
        "summary": "The growth for Vertex’s Journavax painkiller is just beginning to ramp up, given the potential size of the nonaddictive drug market.",
        "pubDate": "2025-10-31T05:30:00Z",
        "displayTime": "2025-10-31T05:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ecf234d0-4e0e-3f80-a374-50144cc8f21f/vertex-pharma%E2%80%99s-stock-has.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/066b6ee2e9d86b0e4ec58aba7281980c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/66u8fpZiU29Kuh0iprHPFA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/066b6ee2e9d86b0e4ec58aba7281980c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iev1NJkEYwkb66i91XAtfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/066b6ee2e9d86b0e4ec58aba7281980c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/vertex-pharmaceutials-stock-tumbled-earnings-pain-4c8409f8?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T16:41:00+00:00",
    "headline": "How Royalty Pharma Prints Cash Without Biotech's Biggest Risks",
    "summary": "Royalty Pharma's recent deals for promising new therapies highlight its unique and successful strategy of funding blockbuster innovation for long-term growth.",
    "url": "https://www.marketbeat.com/originals/how-royalty-pharma-prints-cash-without-biotechs-biggest-risks/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "8324f0de-740a-39ef-a7ce-bd30321409eb",
      "content": {
        "id": "8324f0de-740a-39ef-a7ce-bd30321409eb",
        "contentType": "STORY",
        "title": "How Royalty Pharma Prints Cash Without Biotech's Biggest Risks",
        "description": "",
        "summary": "Royalty Pharma's recent deals for promising new therapies highlight its unique and successful strategy of funding blockbuster innovation for long-term growth.",
        "pubDate": "2025-10-31T16:41:00Z",
        "displayTime": "2025-10-31T16:41:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd",
          "originalWidth": 1200,
          "originalHeight": 674,
          "caption": "Royalty Pharma Information on a phone screen with Royalty Pharma logo in background",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.pYYR.IPZl4FJj4xnqZy3w--~B/aD02NzQ7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd.cf.webp",
              "width": 1200,
              "height": 674,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nCPBboMhrkyMdVMcc9hrtw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/45863e7e786fb8b3f3e4c287e080f1cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/how-royalty-pharma-prints-cash-without-biotechs-biggest-risks/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/royalty-pharma-prints-cash-without-164100203.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBIO"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "RPRX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]